Furthermore, targeting caspase-7 in SW480 cells led to increased cell viability and decreased apoptosis in the presence of SREBP1 downregulation, thereby resulting in decreased sensitivity to chemotherapy drugs, suggesting that targeting SREBP1 sensitizes CRC cells to chemotherapy by caspase-7 upregulation. This evidence concerns the gene CASP7 and colorectal carcinoma.